119 related articles for article (PubMed ID: 3588859)
1. [Histomorphologic changes in Jensen sarcoma following radiotherapy, titanocene dichloride treatment and combination therapy].
Uhl J; Langrock K; Krieghoff B; Hambsch K
Radiobiol Radiother (Berl); 1987; 28(1):51-7. PubMed ID: 3588859
[No Abstract] [Full Text] [Related]
2. [Cyto- and histomorphologic changes in the Jensen sarcoma exposed to cisplatin, radiotherapy and combination treatment].
Langrock K; Kleemann W; Schieck R; Zimmer S; Hambsch K
Radiobiol Radiother (Berl); 1989; 30(6):541-5. PubMed ID: 2608895
[TBL] [Abstract][Full Text] [Related]
3. Tumor inhibition by titanocene complexes: activity against sarcoma 180.
Köpf-Maier P; Preiss F; Marx T; Klapötke T; Köpf H
Anticancer Res; 1986; 6(1):33-7. PubMed ID: 3954328
[TBL] [Abstract][Full Text] [Related]
4. Titanocene dichloride--the first metallocene with cancerostatic activity.
Köpf H; Köpf-Maier P
Angew Chem Int Ed Engl; 1979 Jun; 18(6):477-8. PubMed ID: 111586
[No Abstract] [Full Text] [Related]
5. Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.
Valadares MC; Ramos AL; Rehmann FJ; Sweeney NJ; Strohfeldt K; Tacke M; Queiroz ML
Eur J Pharmacol; 2006 Mar; 534(1-3):264-70. PubMed ID: 16513106
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato) titanium(IV) compounds against Walker 256 carcinosarcoma. A new class of antineoplastic agents.
Keller HJ; Keppler B; Schmähl D
Arzneimittelforschung; 1982; 32(8):806-7. PubMed ID: 6890355
[TBL] [Abstract][Full Text] [Related]
7. [The effectiveness of experimental combined chemical and radiotherapy].
Zedgenidze GA; Amosov IS; Kaperko FF; Kharlampovich SI; Podsosov SP; Tylechkina OD
Med Radiol (Mosk); 1967 Apr; 12(4):3-8. PubMed ID: 6052181
[No Abstract] [Full Text] [Related]
8. Antitumor activity of Titanocene Y against freshly explanted human breast tumor cells and in xenografted MCF-7 tumors in mice.
Beckhove P; Oberschmidt O; Hanauske AR; Pampillón C; Schirrmacher V; Sweeney NJ; Strohfeldt K; Tacke M
Anticancer Drugs; 2007 Mar; 18(3):311-5. PubMed ID: 17264764
[TBL] [Abstract][Full Text] [Related]
9. [Experimental study of the antineoplastic effect of the preparations 141 and 142 of the diethylenimide alkoxybenzylpyrimidilaminophosphoric acid group and the possibility of their use in combination with radiotherapy].
Movsesian MA; Garibdzhanian BT; Barkhudarian LKh; Arutiunian DE; Stepanian GM
Zh Eksp Klin Med; 1977; 17(1):6-10. PubMed ID: 888614
[No Abstract] [Full Text] [Related]
10. Preclinical evaluation of diethoxy-(1-phenyl-1,3-butanedionato) titanium (IV) in human tumour xenografts.
Mattern J; Keppler B; Volm M
Arzneimittelforschung; 1984; 34(10):1289-90. PubMed ID: 6549134
[TBL] [Abstract][Full Text] [Related]
11. Tumor inhibition by titanocene complexes: influence upon two xenografted human lung carcinomas.
Köpf-Maier P
J Cancer Res Clin Oncol; 1987; 113(4):342-8. PubMed ID: 3036884
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma.
Köpf-Maier P
Anticancer Res; 1999; 19(1A):493-504. PubMed ID: 10226588
[TBL] [Abstract][Full Text] [Related]
13. Tumor inhibition by titanocene complexes: influence on xenografted human adenocarcinomas of the gastrointestinal tract.
Köpf-Maier P
Cancer Chemother Pharmacol; 1989; 23(4):225-30. PubMed ID: 2924380
[TBL] [Abstract][Full Text] [Related]
14. Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumors.
Korfel A; Scheulen ME; Schmoll HJ; Gründel O; Harstrick A; Knoche M; Fels LM; Skorzec M; Bach F; Baumgart J; Sass G; Seeber S; Thiel E; Berdel WE
Clin Cancer Res; 1998 Nov; 4(11):2701-8. PubMed ID: 9829732
[TBL] [Abstract][Full Text] [Related]
15. Immunologic response to the treatment of Ehrlich ascites tumor with titanocene dichloride.
Köpf-Maier P; Hesse A
J Cancer Res Clin Oncol; 1984; 108(2):254-5. PubMed ID: 6540782
[TBL] [Abstract][Full Text] [Related]
16. [Experimental treatment of T-1 sarcoma with X-ray and colchamine].
Kharlampovich SI; Kaperko FF; Podsosov SP; Svinogeeva TP
Med Radiol (Mosk); 1968 Jan; 13(1):53-5. PubMed ID: 5742268
[No Abstract] [Full Text] [Related]
17. Enhancement of antitumor response to sarcoma 45 in rats by combination of whole-body hyperthermia and interleukin-2.
Potapnev MP; Istomin YP; Ismail-zade RS; Zhavrid EA
Eksp Onkol; 2004 Mar; 26(1):67-70. PubMed ID: 15112583
[TBL] [Abstract][Full Text] [Related]
18. Activity of titanocene dihalides against a human colon carcinoma heterotransplanted to athymic mice.
Köpf-Maier P; Moormann A; Köpf H
Eur J Cancer Clin Oncol; 1985 Jul; 21(7):853-7. PubMed ID: 4043173
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative activity of Titanocene Y against tumor colony-forming units.
Oberschmidt O; Hanauske AR; Pampillón C; Sweeney NJ; Strohfeldt K; Tacke M
Anticancer Drugs; 2007 Mar; 18(3):317-21. PubMed ID: 17264765
[TBL] [Abstract][Full Text] [Related]
20. [Combined use of metronidazole and short-term hyperglycemia during radiation therapy of tumors in rats].
Vepkhvadze NR; Iarmonenko SP
Radiobiologiia; 1985; 25(3):333-7. PubMed ID: 4023185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
